China’s Anti-Corruption Investigation May Last At Least Three Years
This article was originally published in PharmAsia News
Executive Summary
A “thorough anti-corruption investigation” in medical industry started with GlaxoSmithKline’s bribery scandal seven months ago, and China’s regulatory authorities claim that investigation of the entire medical industry will last for three years to 2015.